GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Other Stockholders Equity

HLB Science (XKRX:343090) Other Stockholders Equity : ₩0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Other Stockholders Equity?

HLB Science's Other Stockholders Equity for the quarter that ended in . 20 was ₩0.00 Mil.

HLB Science's annual Other Stockholders Equity increased from . 20 (₩0.00 Mil) to Dec. 2022 (₩169.00 Mil) and increased from Dec. 2022 (₩169.00 Mil) to Dec. 2023 (₩186.40 Mil).


HLB Science Other Stockholders Equity Historical Data

The historical data trend for HLB Science's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Other Stockholders Equity Chart

HLB Science Annual Data
Trend Dec22 Dec23
Other Stockholders Equity
169.00 186.40

HLB Science Quarterly Data
Other Stockholders Equity

HLB Science Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


HLB Science Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of HLB Science's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines